• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Long-term results of medical treatment in Mycobacterium intracellulare infection.

作者信息

Dutt A K, Stead W W

出版信息

Am J Med. 1979 Sep;67(3):449-53. doi: 10.1016/0002-9343(79)90792-7.

DOI:10.1016/0002-9343(79)90792-7
PMID:474589
Abstract
摘要

相似文献

1
Long-term results of medical treatment in Mycobacterium intracellulare infection.胞内分枝杆菌感染的药物治疗长期结果
Am J Med. 1979 Sep;67(3):449-53. doi: 10.1016/0002-9343(79)90792-7.
2
[Intermittent chemotherapy of pulmonary tuberculosis with rifampicin and ethambutol].
Probl Tuberk. 1978 Oct(10):28-30.
3
Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii.堪萨斯分枝杆菌所致肺部疾病的短程化疗
Am Rev Respir Dis. 1983 Dec;128(6):1048-50. doi: 10.1164/arrd.1983.128.6.1048.
4
[Dynamics of specific changes in recurrences of pulmonary tuberculosis in relation to chemotherapy schedules].[肺结核复发的特定变化动态与化疗方案的关系]
Probl Tuberk. 1991(10):53-5.
5
Cavitary lung infection caused by Mycobacterium flavescens.淡黄分枝杆菌引起的肺部空洞感染。
South Med J. 1982 Feb;75(2):253-4. doi: 10.1097/00007611-198202000-00042.
6
[Fever and thin-walled cavitary lung lesions].[发热与薄壁肺空洞病变]
Enferm Infecc Microbiol Clin. 2009 Jun;27(6):363-4. doi: 10.1016/j.eimc.2008.07.010. Epub 2009 May 6.
7
[Urgent problems of antibacterial treatment of pulmonary tuberculosis].[肺结核抗菌治疗的紧迫问题]
Vrach Delo. 1981 Jan(1):47-9.
8
The antituberculosis efficacy of rifampin in 136 patients.
Chest. 1972 Jun;61(6):574-8. doi: 10.1016/s0012-3692(15)39158-3.
9
Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection.标准化三联药物方案治疗非结核分枝杆菌肺部感染的疗效
Clin Infect Dis. 2008 Jul 15;47(2):222-4. doi: 10.1086/589250.
10
Rifampicin, isoniazid, ethambutol, ethionamide, and streptomycin in murine tuberculosis: comparative chemotherapeutic studies.
Antibiot Chemother. 1970;16:352-60. doi: 10.1159/000386838.

引用本文的文献

1
Mycobacterium avium Complex Disease.鸟分枝杆菌复合体病。
Microbiol Spectr. 2017 Apr;5(2). doi: 10.1128/microbiolspec.TNMI7-0045-2017.
2
Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease.对782例结节性/支气管扩张型鸟分枝杆菌复合群肺病患者的死亡率和影像学恶化预测因素的回顾性研究。
BMJ Open. 2015 Aug 5;5(8):e008058. doi: 10.1136/bmjopen-2015-008058.
3
First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
针对HIV阴性患者中由胞内鸟分枝杆菌、马尔默分枝杆菌和蟾分枝杆菌引起的肺部疾病治疗的首个随机试验：利福平、乙胺丁醇和异烟肼与利福平和乙胺丁醇的对比
Thorax. 2001 Mar;56(3):167-72. doi: 10.1136/thorax.56.3.167.
4
Risk-benefit assessment of therapies for Mycobacterium avium complex infections.鸟分枝杆菌复合群感染治疗的风险效益评估。
Drug Saf. 1999 Aug;21(2):137-52. doi: 10.2165/00002018-199921020-00006.
5
Susceptibility testing of Mycobacterium avium complex isolates.鸟分枝杆菌复合体分离株的药敏试验
Antimicrob Agents Chemother. 1996 Aug;40(8):1759-67. doi: 10.1128/AAC.40.8.1759.
6
Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex.鸟分枝杆菌-胞内分枝杆菌复合群分枝杆菌引起的肺部感染的治疗。
Thorax. 1981 May;36(5):326-9. doi: 10.1136/thx.36.5.326.
7
In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex.乙胺丁醇、异烟肼、卡那霉素、利福平及链霉素对鸟分枝杆菌-胞内分枝杆菌复合体的体外协同活性
Antimicrob Agents Chemother. 1982 Jul;22(1):148-50. doi: 10.1128/AAC.22.1.148.
8
Rapid drug susceptibility testing of mycobacteria in tissue culture medium.在组织培养基中对分枝杆菌进行快速药敏试验。
Antimicrob Agents Chemother. 1983 Aug;24(2):268-72. doi: 10.1128/AAC.24.2.268.
9
In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.诺氟沙星和环丙沙星对结核分枝杆菌、鸟分枝杆菌复合体、龟分枝杆菌、偶然分枝杆菌和堪萨斯分枝杆菌的体外活性。
Antimicrob Agents Chemother. 1984 Jul;26(1):94-6. doi: 10.1128/AAC.26.1.94.
10
Comparative in vitro activities of MDL 473, rifampin, and ansamycin against Mycobacterium intracellulare.MDL 473、利福平及安莎霉素对胞内分枝杆菌的体外比较活性
Antimicrob Agents Chemother. 1985 Sep;28(3):440-1. doi: 10.1128/AAC.28.3.440.